# Peerless Hospital Guwahati Urges Women to Recognize Signs of Polyendocrine Metabolic Ovarian Syndrome

> Polycystic Ovary Syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome. Peerless Hospital Guwahati highlights the condition during awareness month and urges women to seek medical advice.

**Type:** article · **Category:** Assam · **Published:** 2026-09-28 · **Source:** TrendKia
**Canonical:** https://trendkia.com/en/assam/peerless-hospital-guwahati-urges-women-to-recognise-signs-of-polyendocrine-metabolic-ovarian-syndrome-39817 · **Language:** English
**Tags:** PMOS, PCOS, Peerless Hospital Guwahati, Women Health, Health Awareness

Polycystic Ovary Syndrome (PCOS), now officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), stands as one of the most widespread endocrine disorders impacting women of reproductive age. Despite its high prevalence, a significant proportion of individuals living with this condition remain undiagnosed and unaware of their underlying health status. Following a global consensus process that culminated in May 2026, the condition underwent an official renaming to better reflect its multifaceted endocrine, metabolic, and ovarian dimensions, along with its broader health implications.

 

## Awareness Month and Guwahati Initiatives
 As September marks PCOS and PMOS Awareness Month, Peerless Hospital Guwahati is actively emphasizing the critical need to recognize the condition far beyond its traditional association with irregular menstrual cycles and infertility. The healthcare institution encourages women experiencing persistent symptoms to seek professional medical guidance without hesitation. According to updated international PMOS guidelines, the condition affects roughly one in every eight women of reproductive age, translating to over 170 million women globally, while up to 70 percent of affected individuals may live without a formal diagnosis.

 

## The Global Consensus and Terminology Shift
 The updated nomenclature stems from a rigorous multistep global consensus initiative involving professional medical associations, patient advocacy groups, healthcare practitioners, and individuals with firsthand lived experience. Although the May 2026 update alters the terminology and overarching clinical framing, the core clinical recommendations and content embedded within the international guidelines remain intact, with PMOS slated for formal integration as standard terminology in the upcoming 2028 International Guideline. This deliberate shift in terminology mirrors decades of accumulated research demonstrating that the syndrome extends well beyond the boundaries of the ovaries.

 Labeling the condition as a 'polycystic ovary' has long proven misleading, because the specific ovarian appearance linked to the disorder actually signifies arrested follicular development rather than true pathological ovarian cysts. Furthermore, the previous reproduction-centric title frequently obscured the metabolic, cardiovascular, dermatological, and psychological components of the condition, ultimately resulting in delayed diagnoses, fragmented patient care, and persistent social stigma.

 

## Clinical Presentation and Expert Insights
 PMOS can manifest differently across individuals, making its clinical identification diverse. Irregular or infrequent menstrual periods, challenges in conceiving, persistent acne, excess facial or body hair growth, thinning scalp hair, and noticeable weight fluctuations represent common signs. However, healthcare experts stress that the absence of any single specific symptom does not automatically rule out the condition. Dr. Ishita Das, Consultant Gynecologist at Peerless Hospital Guwahati, noted that the transition from PCOS to PMOS is vital because it accurately captures modern medical understanding.

 Dr. Das explained that PMOS is not merely a menstrual irregularity nor is it synonymous with infertility or excess body weight. Instead, it operates as a complex endocrine and metabolic condition whose presentation varies considerably from one woman to another. While some patients primarily experience disrupted menstrual cycles, others encounter acne, excessive facial or body hair, hair thinning, or ovulation difficulties. Crucially, women who maintain a lean physique or normal body weight can also develop PMOS, meaning symptoms must be evaluated collectively rather than judged solely on weight or isolated signs.

 

## Diagnostic Precision Beyond Ultrasounds
 Diagnostic protocols should rely on comprehensive clinical assessments rather than depending exclusively on ultrasound reports. A frequent misconception involves assuming that spotting multiple small follicles on an ultrasound automatically confirms PMOS, which is frequently untrue. In adult patients, diagnosis requires evaluating features such as ovulatory dysfunction alongside clinical or biochemical indicators of hyperandrogenism, utilizing ovarian morphology on ultrasound or Anti-Mullerian Hormone levels where appropriate as diagnostic components. Other conditions presenting similar symptoms must also be systematically excluded, making self-diagnosis via internet searches or isolated scan results highly misleading.

 Beyond reproductive health, PMOS carries considerable systemic implications. Affected women face an elevated susceptibility to impaired glucose tolerance and type 2 diabetes, while cardiovascular risk factors like high blood pressure and abnormal cholesterol levels demand careful attention. Additionally, the condition correlates with sleep disorders and psychological challenges, including anxiety, depression, eating disorders, and negative body image perceptions. Managing PMOS extends far past regulating periods or addressing fertility goals, requiring comprehensive monitoring of metabolic, cardiovascular, and psychological well-being.

 

## Long-Term Management and Lifestyle Strategies
 Current clinical guidelines advise evaluating glycemic status and cardiovascular risk factors for women diagnosed with PMOS, regardless of age or Body Mass Index. This monitoring proves especially vital because metabolic risks frequently exist even when a patient does not appear overweight. Although no single cure currently exists for PMOS, the condition can be managed effectively through tailored combinations of lifestyle interventions and medical treatments customized to each patient's symptoms, reproductive objectives, and metabolic health profile.

 Dr. Das emphasized that treatment lacks a universal approach. Nutritious eating, regular physical activity, sufficient sleep, and preventing excessive weight gain form the bedrock of long-term care, though lifestyle management must never be reduced strictly to weight loss. Depending on individual needs, medical therapies may address menstrual irregularities, hyperandrogenic manifestations, or metabolic concerns. The ultimate objective centers on establishing a sustained health plan rather than merely treating individual symptoms in isolation.

 

## Fertility Realities and Medical Supervision
 Importantly, receiving a PMOS diagnosis does not mean a woman will inevitably face lifelong infertility. While the condition remains a leading driver of ovulatory infertility, natural conception is entirely possible for many, while others benefit from medical assistance to restore or induce ovulation. Early medical consultation helps identify specific barriers to conception, allowing appropriate therapeutic interventions. Women should therefore avoid assuming that a PMOS diagnosis precludes motherhood.

 Highlighting the broader value of community awareness, Dr. Pranab Barua, Medical Superintendent at Peerless Hospital Guwahati, noted that awareness and timely healthcare access form cornerstone pillars of preventive medicine. Conditions like PMOS impact multiple life stages, and heightened awareness encourages women to seek professional guidance rather than normalizing persistent discomfort. Assam CM reviews arrangements for Bhupen Hazarika centenary finale in Delhi, reflecting broader state developments alongside healthcare outreach. The hospital remains dedicated to providing informed, compassionate, and comprehensive patient support, urging individuals experiencing persistent reproductive or dermatological irregularities to consult qualified professionals rather than relying on unverified online resources.

## What this means for you
Increased awareness surrounding Polyendocrine Metabolic Ovarian Syndrome empowers women to identify early symptoms and consult medical professionals promptly.

- **Across India:** Affecting roughly one in eight women of reproductive age, early screening and intervention help mitigate long-term risks of diabetes and cardiovascular issues nationwide.

- **In Guwahati:** Local women can leverage guidance from Peerless Hospital Guwahati to bypass unverified internet myths and obtain accurate clinical evaluations from qualified specialists.

- **Comprehensive Screening:** Patients should undergo holistic metabolic, hormonal, and psychological assessments rather than focusing solely on isolated reproductive symptoms or irregular periods.

- **Fertility Management:** Receiving a diagnosis does not preclude motherhood, as timely medical advice and ovulation support enable successful natural or assisted conceptions.

## Why this happened
The recent terminology update stems from decades of medical research and a comprehensive global consensus process designed to reflect the syndrome's full scope.

- **Scientific Evolution:** The legacy term 'polycystic ovary' proved misleading because arrested follicular development differs from true pathological cysts in a systemic endocrine disorder.

- **Global Consensus:** A multistep international consensus process concluding in May 2026 brought together healthcare professionals, patient advocates, and researchers to update the framework.

- **Delayed Diagnoses:** A narrow reproduction-centric title previously obscured metabolic, cardiovascular, and psychological dimensions, contributing to fragmented care and delayed identification.

## Questions & Answers

### 1. What is the new name for Polycystic Ovary Syndrome?
Following a May 2026 global consensus, the condition has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).

### 2. How many women are affected by PMOS globally?
The condition affects approximately one in eight women of reproductive age, impacting over 170 million women worldwide.

### 3. Does a PMOS diagnosis mean a woman cannot have children?
No, while it is a leading cause of ovulatory infertility, many women conceive naturally or successfully utilize medical assistance.

### 4. Can PMOS be diagnosed using an ultrasound report alone?
No, spotting small follicles on an ultrasound does not automatically confirm PMOS, as comprehensive clinical assessment and symptom evaluation are required.

### 5. What does Peerless Hospital Guwahati advise women to do?
The hospital encourages women experiencing persistent symptoms to consult qualified healthcare professionals rather than relying on unverified internet information.

---
_TrendKia — Har trend, sabse pehle.. Machine-readable view; canonical HTML at the URL above._